Φορτώνει......
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes
Type 1 diabetes (T1D) is characterized by specific destruction of pancreatic insulin-producing beta cells accompanied by evidence of beta-cell-directed autoimmunity such as autoreactive T cells and islet autoantibodies (IAAs). Currently, T1D cannot be prevented or reversed in humans. T1D is easy to...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Immunotargets Ther |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5448691/ https://ncbi.nlm.nih.gov/pubmed/28580341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S117264 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|